Wang Luquan

This profile gathers the share dealings of Wang Luquan in Genscript Biotech Corporation. The record holds 106 filings, for trades running from 13 July 2017 to 21 May 2025.

The open-market side counts 6 purchases for €216.2M alongside 55 sales for €455.5M. The totals do not cover 4 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at no purchases and 7 sales.

The median purchase comes to €409k.

Most recently, on 23 May 2025, the filings show an open-market sale worth €6.8M in Genscript Biotech Corporation. The latest purchase dates back some time: it was published 1,966 days ago, on 3 June 2021. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.